Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c33b8d6e85644ca822b55dbf9026bb64 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 |
filingDate |
2012-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64f86442ee91fae6e159cd1194853008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9bfdb6fa818bc5d24c173685c2da714 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0509b1a56c13df59519dbe3cb09ad01a |
publicationDate |
2020-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2859156-C |
titleOfInvention |
Treatment of type i and type ii diabetes |
abstract |
The present invention provides a use of insulin and a phenoxypyrimidinone compound for treating Type I or Type II diabetes in a mammal, and formulations for carrying out the uses. |
priorityDate |
2011-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |